The bull run in medtech venture financing activity continued in July, with deal volume going up once again from the previous month. Deal value was also solid, boosted by a number of sizeable rounds that helped lift the total amount of venture dollars raised this year to date to $3.88bn. Barring the possibility of a sudden drought in the VC financing landscape in the next few months, 2017 should be in a good position to beat 2016 in total deal value.

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

In this issue, we present another installment of our quarterly review of dealmaking-for October-December 2004. Our data comes from Windhover's Strategic Transactions Database, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries.